Clinical Trial Update: Clinical Pharmacokinetics Study of ART-123 in Disseminated Intravascular Coagulation (DIC) Subjects With Renal Impairment [Phase 4]

View source ↗

Summary

Phase 4 pharmacokinetics study of ART-123 in patients with disseminated intravascular coagulation and renal impairment has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Disseminated Intravascular Coagulation

Drugs mentioned

• ART-123 (recombinant human soluble thrombomodulin)

Snippet

Sponsor: Asahi Kasei Therapeutics Corporation | Conditions: Disseminated Intravascular Coagulation | Phase 4 | Status: COMPLETED